Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial IDDO_EORKWS

Domain:

healthcare

Record type:

dataset

Creator:

Uni

Publisher:

Inf

Host:

Patient records from open-label, single arm trial to investigate the efficacy of TKM-130803 collected by Oxford University during the 2013-2016 West African Ebola outbreak. It has been curated to the CDISC SDTM data standard at the individual participant-level for 17 participants. Further information about the data available in this dataset can be found on the IDDO website.

Visit

doi.org doi.iddo.org

Licenses

IDDO Data Platform Data Transfer Agreement https://www.iddo.org/document/iddo-data-use-agreement

Experimental treatment of Ebola virus disease with brincidofovir

The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double

Experimental Treatment of Ebola Virus Disease with Brincidofovir IDDO_EBPOHA

Patient records from the clinical trial titled Experimental Treatment of EVD with Brincidofovir, col

Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients.

BACKGROUND: TKM-130803 is a specific anti-EBOV therapeutic comprised of two small interfering RNAs (

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.

BACKGROUND: Limited treatment data are available for hepatitis C virus (HCV) in

Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic

The first Phase II and III clinical trials for treatments for Ebola Virus Disease were conducted dur

PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors

Abstract Background Ebola virus RNA persist